Article Text

PDF

Kidney and cardiovascular disease
The therapy of microalbuminuric patients with type 2 diabetes mellitus and hypertension
  1. Fu Xin,
  2. Huang Zhenwen
  1. Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

Abstract

Objective To delineate the speculation that triple combination of small doses of calcium antagonist (levoamlodipine), ACEI (imidapril) and ARB (candesartan) may exert more significantly effect on microalbuminuria (MAU) in patients with type 2 of diabetes mellitus and hypertension.

Methods One hundred sixty cases of consecutive patients with type 2 diabetes mellitus and hypertension were randomised to receive following various combinations: amlodipine 2.5 mg/candesartan 4 mg (n=40), candesartan 4 mg/imidapril 5 mg (n=40); imidapril 5 mg/amlodipine 2.5 mg (n=40), and amlodipine 2.5 mg/candesartan 4 mg plus imidapril 5 mg (n=40). The changes in blood pressure and MAU were determined before and after treatment.

Results Four drug combinations of treatment all significantly lowered BP (p<0.05), with no significantly statistical difference among the all various combination treatments decreased urine MAU (p<0.01), however the three drugs combination treatment group decreased MAU more significantly than those by two drugs combination treatments (p<0.05).

Conclusion Low dose of triple drugs combination (candesartan, imidapril and levoamlodipine) is more effective in improving early renal damage of patients with diabetes mellitus and hypertension than that by two drugs combination.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.